These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 28876468)
41. N-cadherin, a novel prognostic biomarker, drives malignant progression of colorectal cancer. Yan X; Yan L; Liu S; Shan Z; Tian Y; Jin Z Mol Med Rep; 2015 Aug; 12(2):2999-3006. PubMed ID: 25936636 [TBL] [Abstract][Full Text] [Related]
42. Downregulation of DHRS9 expression in colorectal cancer tissues and its prognostic significance. Hu L; Chen HY; Han T; Yang GZ; Feng D; Qi CY; Gong H; Zhai YX; Cai QP; Gao CF Tumour Biol; 2016 Jan; 37(1):837-45. PubMed ID: 26254099 [TBL] [Abstract][Full Text] [Related]
43. Transcriptome analysis of CD133-positive stem cells and prognostic value of survivin in colorectal cancer. Kim ST; Sohn I; DO IG; Jang J; Kim SH; Jung IH; Park JO; Park YS; Talasaz A; Lee J; Kim HC Cancer Genomics Proteomics; 2014; 11(5):259-66. PubMed ID: 25331798 [TBL] [Abstract][Full Text] [Related]
44. Chemokine (C-X-C motif) ligand 1 is associated with tumor progression and poor prognosis in patients with colorectal cancer. Zhuo C; Wu X; Li J; Hu D; Jian J; Chen C; Zheng X; Yang C Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29784873 [TBL] [Abstract][Full Text] [Related]
45. Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinoma. Wu Q; Yang Y; Wu S; Li W; Zhang N; Dong X; Ou Y Diagn Pathol; 2015 Sep; 10():176. PubMed ID: 26408312 [TBL] [Abstract][Full Text] [Related]
46. The role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer. Duncan TJ; Watson NF; Al-Attar AH; Scholefield JH; Durrant LG World J Surg Oncol; 2007 Mar; 5():31. PubMed ID: 17349047 [TBL] [Abstract][Full Text] [Related]
47. Elevated OCT1 participates in colon tumorigenesis and independently predicts poor prognoses of colorectal cancer patients. Wang YP; Song GH; Chen J; Xiao C; Li C; Zhong L; Sun X; Wang ZW; Deng GL; Yu FD; Xue YM; Tang HM; Peng ZH; Wang XL Tumour Biol; 2016 Mar; 37(3):3247-55. PubMed ID: 26433389 [TBL] [Abstract][Full Text] [Related]
48. Low expression of RASSF10 is associated with poor survival in patients with colorectal cancer. Wang F; Li P; Feng Y; Hu YL; Liu YF; Guo YB; Jiang XL; Mao QS; Xue WJ Hum Pathol; 2017 Apr; 62():108-114. PubMed ID: 28041974 [TBL] [Abstract][Full Text] [Related]
49. [Expression and significance of Bmi-1 and Ki67 in colorectal carcinoma tissues]. Lin MX; Wen ZF; Feng ZY; He D Ai Zheng; 2008 Dec; 27(12):1321-6. PubMed ID: 19080002 [TBL] [Abstract][Full Text] [Related]
50. Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer. Toiyama Y; Yasuda H; Saigusa S; Tanaka K; Inoue Y; Goel A; Kusunoki M Carcinogenesis; 2013 Nov; 34(11):2548-57. PubMed ID: 24001454 [TBL] [Abstract][Full Text] [Related]
51. High expression of Y-box-binding protein 1 is associated with local recurrence and predicts poor outcome in patients with colorectal cancer. Yan X; Yan L; Zhou J; Liu S; Shan Z; Jiang C; Tian Y; Jin Z Int J Clin Exp Pathol; 2014; 7(12):8715-23. PubMed ID: 25674237 [TBL] [Abstract][Full Text] [Related]
52. Prognostic significance of S100A4 mRNA and protein expression in colorectal cancer. Kang YG; Jung CK; Lee A; Kang WK; Oh ST; Kang CS J Surg Oncol; 2012 Feb; 105(2):119-24. PubMed ID: 21837681 [TBL] [Abstract][Full Text] [Related]
53. High levels of SIRT1 expression enhance tumorigenesis and associate with a poor prognosis of colorectal carcinoma patients. Chen X; Sun K; Jiao S; Cai N; Zhao X; Zou H; Xie Y; Wang Z; Zhong M; Wei L Sci Rep; 2014 Dec; 4():7481. PubMed ID: 25500546 [TBL] [Abstract][Full Text] [Related]
54. Overexpression of Transcription Termination Factor 1 is Associated with a Poor Prognosis in Patients with Colorectal Cancer. Ueda M; Iguchi T; Nambara S; Saito T; Komatsu H; Sakimura S; Hirata H; Uchi R; Takano Y; Shinden Y; Eguchi H; Masuda T; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1490-8. PubMed ID: 26036188 [TBL] [Abstract][Full Text] [Related]
55. KIF2A overexpression and its association with clinicopathologic characteristics and unfavorable prognosis in colorectal cancer. Fan X; Wang X; Zhu H; Wang W; Zhang S; Wang Z Tumour Biol; 2015 Nov; 36(11):8895-902. PubMed ID: 26070867 [TBL] [Abstract][Full Text] [Related]
56. Gremlin1 expression associates with serrated pathway and favourable prognosis in colorectal cancer. Pelli A; Väyrynen JP; Klintrup K; Mäkelä J; Mäkinen MJ; Tuomisto A; Karttunen TJ Histopathology; 2016 Nov; 69(5):831-838. PubMed ID: 27257976 [TBL] [Abstract][Full Text] [Related]
57. GATA binding protein 2 overexpression is associated with poor prognosis in KRAS mutant colorectal cancer. Xu K; Wang J; Gao J; Di J; Jiang B; Chen L; Wang Z; Wang A; Wu F; Wu W; Shen L; Su X Oncol Rep; 2016 Sep; 36(3):1672-8. PubMed ID: 27460045 [TBL] [Abstract][Full Text] [Related]
58. Identification and characterization of ANO9 in stage II and III colorectal carcinoma. Li C; Cai S; Wang X; Jiang Z Oncotarget; 2015 Oct; 6(30):29324-34. PubMed ID: 26317553 [TBL] [Abstract][Full Text] [Related]